期刊文献+

血清癌胚抗原、糖类抗原199、糖类抗原724检测对胃癌的诊断价值 被引量:13

Diagnosis value of serum carcinoembryonic antigen and carbohydrate antigen 199 and carbohydrate antigen 724 on gastric carcinoma
下载PDF
导出
摘要 目的了解肿瘤标志物癌胚抗原(CEA)、糖类抗原199(CA199)、糖类抗原724(CA724)在胃癌中的表达情况,为临床诊断提供参考依据。方法选择2010年1月~2012年3月在我院就诊的胃癌患者(106例)、胃良性疾病患者(138例)、健康体检人群(122例)为研究对象,检测所有对象血清中CEA、CA199、CA724的含量。结果胃癌患者三项指标均高于胃良性疾病组及健康对照组(P<0.05),三项指标在胃良性疾病组及健康组之间差异无统计学意义。Ⅲ、Ⅳ期和有肝转移胃癌患者的三项标志物水平及阳性率均高于Ⅰ~Ⅱ期和无肝转移患者(P<0.05)。结论胃癌患者血清CEA、CA199及CA724水平与胃癌的发生、发展密切相关,三者联合检测对胃癌患者的早期诊断、治疗和预后判断具有较高的实用价值。 Objective To explore the expression level of CEA, CA199, CA724 in gastric carcinoma, in order to provide in- formation for clinical diagnosis. Methods Testing the level of CEA, CA199, CA724 all were selected as the study objects of the patients with gastric carcinoma and patients with benign gastric disease and healthy people. Results The level of the three parameters of the gastric carcinoma group was higher than those of the benign gastric disease group and healthy con- trol group (P 〈 0.05), However, there was not statistical difference of the three parameters between the benign gastric dis- ease group and healthy control group. The positive rates were obviously higher than those during Ⅰ - Ⅱ stage and without liver metastasis of these three tumor marker in patients with gastric cancer during m, Iv stage and liver metastasis (P 〈 0.05). Conclusion Testing the level of the serum CEA, CA199, CA724 are closely related with gastric cancer patients oc- eurreneing and developing, three markers combined detection have higher practical value for gastric cancer in early diag- nosis and therapy and prognosis estimation.
出处 《中国医药导报》 CAS 2012年第28期89-90,95,共3页 China Medical Herald
关键词 胃癌 肿瘤标志物 癌胚抗原 糖类抗原199 糖类抗原724 Gastric tumor , Tumor marker Carcinoembryonic antigen Carbohydrate antigen 199 Carbohydrate antigen 724
  • 相关文献

参考文献6

二级参考文献15

共引文献32

同被引文献106

  • 1胃癌诊疗规范(2011年版)[J].中国医学前沿杂志(电子版),2012,4(5):62-71. 被引量:244
  • 2吴健民.对肿瘤标志物的再认识[J].中华检验医学杂志,2005,28(1):11-13. 被引量:116
  • 3林裕龙,龙国进,兰萌,莫炳强,彭永正,冯桂湘.幽门螺旋杆菌抗体谱检测在不同消化系统疾病的临床意义[J].广东医学,2006,27(12):1887-1888. 被引量:7
  • 4Yeung BH,Law AY,Wong CK. Evolution and roles of stanniocalcin [J]. Mol Cell Endocrinol,2012,349 (2): 272-280.
  • 5Yokobori T, Mimori K,Ishii H,et al. Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer [J]. Ann Surg Oncol, 2010,17 (10) : 2601-2607.
  • 6Law AY,Wong CK. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia [J]. Exp Cell Res,2010,316(3) :466-476.
  • 7Law AY,Wong CK. Stanniocalcin-1 and -2 promote an- giogenic sprouting in HUVECs via VEGF/VEGFR2 and angiopoietin signaling pathways [J]. Mol Cell Endocrinol, 2013.374(1-2) ._73-81.
  • 8Yuan Y,Yang ZL,Zou Q,et al. A Comparative study of clinicopathological significance, BIRC7,and STC2 ex- pression between squamous cell/adenosquamous carcino mas and adenocarcinoma of gallbladder[J]. Neoplasma,2013, 60 (6) : 698-705.
  • 9Kita Y,Mimori K,Iwatsuki M,et al. STC2:a predictive marker for lymph node metastasis in esophageal squa- mous-cell carcinoma [J]. Ann Surg Oncol, 2011,18 (1) : 261- 272.
  • 10Ieta K,Tanaka F,Yokobori T,et al. Clinicopathological significance of stanniocalcin 2 gene expression in colorec- tal cancer [J]. Int J Cancer,2009,125(4) :926-931.

引证文献13

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部